Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Jennifer R. Brown; Wael A. Harb; Brian T. Hill; Janice Gabrilove; Jeff P. Sharman; Marshall T. Schreeder; Paul M. Barr; James M. Foran; Thomas P. Miller; Jan A. Burger; Kevin R. Kelly; Daruka Mahadevan; Shuo Ma; Yan Li; Daniel W. Pierce; Evelyn Barnett; Jeffrey Marine; Monika Miranda; Ada Azaryan; Xujie Yu; Pilar Nava-Parada; Jay Mei; Thomas J. Kipps

doi:10.3324/haematol.2015.140806

Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Jennifer R. Brown, Wael A. Harb, Brian T. Hill, Janice Gabrilove, Jeff P. Sharman, Marshall T. Schreeder, Paul M. Barr, James M. Foran, Thomas P. Miller, Jan A. Burger, Kevin R. Kelly, Daruka Mahadevan, Shuo Ma, Yan Li, Daniel W. Pierce, Evelyn Barnett, Jeffrey Marine, Monika Miranda, Ada Azaryan, Xujie YuPilar Nava-Parada, Jay Mei, Thomas J. Kipps

Research output: Contribution to journal › Letter › peer-review

61 Scopus citations

Original language	English (US)
Pages (from-to)	e295-e298
Journal	Haematologica
Volume	101
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2015.140806
State	Published - 2016
Externally published	Yes

Keywords

BTK inhibitors
CC-292
Chronic lymphocytic leukemia
Refractory
Relapsed
Single-agent
Small lymphocytic lymphoma

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2015.140806

Cite this

Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D. W., Barnett, E., Marine, J., Miranda, M., Azaryan, A., ... Kipps, T. J. (2016). Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia. Haematologica, 101(7), e295-e298. https://doi.org/10.3324/haematol.2015.140806

Brown, JR, Harb, WA, Hill, BT, Gabrilove, J, Sharman, JP, Schreeder, MT, Barr, PM, Foran, JM, Miller, TP, Burger, JA, Kelly, KR, Mahadevan, D, Ma, S, Li, Y, Pierce, DW, Barnett, E, Marine, J, Miranda, M, Azaryan, A, Yu, X, Nava-Parada, P, Mei, J & Kipps, TJ 2016, 'Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia', Haematologica, vol. 101, no. 7, pp. e295-e298. https://doi.org/10.3324/haematol.2015.140806

@article{6c7f2d84d0ff409c861cd923de430bea,

title = "Phase I study of single-agent CC-292, a highly selective bruton{\textquoteright}s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia",

keywords = "BTK inhibitors, CC-292, Chronic lymphocytic leukemia, Refractory, Relapsed, Single-agent, Small lymphocytic lymphoma",

author = "Brown, \{Jennifer R.\} and Harb, \{Wael A.\} and Hill, \{Brian T.\} and Janice Gabrilove and Sharman, \{Jeff P.\} and Schreeder, \{Marshall T.\} and Barr, \{Paul M.\} and Foran, \{James M.\} and Miller, \{Thomas P.\} and Burger, \{Jan A.\} and Kelly, \{Kevin R.\} and Daruka Mahadevan and Shuo Ma and Yan Li and Pierce, \{Daniel W.\} and Evelyn Barnett and Jeffrey Marine and Monika Miranda and Ada Azaryan and Xujie Yu and Pilar Nava-Parada and Jay Mei and Kipps, \{Thomas J.\}",

year = "2016",

doi = "10.3324/haematol.2015.140806",

language = "English (US)",

volume = "101",

pages = "e295--e298",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

TY - JOUR

T1 - Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

AU - Brown, Jennifer R.

AU - Harb, Wael A.

AU - Hill, Brian T.

AU - Gabrilove, Janice

AU - Sharman, Jeff P.

AU - Schreeder, Marshall T.

AU - Barr, Paul M.

AU - Foran, James M.

AU - Miller, Thomas P.

AU - Burger, Jan A.

AU - Kelly, Kevin R.

AU - Mahadevan, Daruka

AU - Ma, Shuo

AU - Li, Yan

AU - Pierce, Daniel W.

AU - Barnett, Evelyn

AU - Marine, Jeffrey

AU - Miranda, Monika

AU - Azaryan, Ada

AU - Yu, Xujie

AU - Nava-Parada, Pilar

AU - Mei, Jay

AU - Kipps, Thomas J.

PY - 2016

Y1 - 2016

KW - BTK inhibitors

KW - CC-292

KW - Chronic lymphocytic leukemia

KW - Refractory

KW - Relapsed

KW - Single-agent

KW - Small lymphocytic lymphoma

UR - https://www.scopus.com/pages/publications/84977137696

UR - https://www.scopus.com/inward/citedby.url?scp=84977137696&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.140806

DO - 10.3324/haematol.2015.140806

M3 - Letter

C2 - 27151992

AN - SCOPUS:84977137696

SN - 0390-6078

VL - 101

SP - e295-e298

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this